reserpine has been researched along with muscarine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, M; Drum, P; Jurna, I | 1 |
| Day, M; Nathanson, NM; Shen, W; Surmeier, DJ; Tian, X; Tkatch, T; Ulrich, S | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
4 other study(ies) available for reserpine and muscarine
| Article | Year |
|---|---|
Abolition of spinal motor disturbance by injections of dopamine receptor agonists, atropin and GABA into the caudate nucleus.
Topics: Aminobutyrates; Animals; Atropine; Caudate Nucleus; Female; gamma-Aminobutyric Acid; Hydroxydopamines; Injections; Male; Motor Neurons; Muscarine; Nicotine; Rats; Receptors, Dopamine; Reflex; Reserpine; Spinal Cord; Substantia Nigra | 1978 |
Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons.
Topics: Animals; Animals, Newborn; Corpus Striatum; Dendrites; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Green Fluorescent Proteins; In Vitro Techniques; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscarine; Muscarinic Agonists; Neurons; Oxidopamine; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Receptor, Muscarinic M1; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Signal Transduction | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |